0       0

HFSA's 20th Annual Scientific Meeting


The Prevention of HF (Joint Session with AHA)


Description

  • The Definition of HF in Epidemiologic Studies: Are We Underestimating the Prevalence?
  • Hypertension and HF: Has SPRINT Taught Us Something New?
  • Diabetes and HF: Is There Hope in SGLT2 Inhibitors?
  • Panel Discussion Moderator
  • Can we Prevent HF Following Chemotherapy- Can We Predict It?
  • Now that HIV is a Chronic Disease – Is it Leading to HF?
  • Biomarkers Used to Predict and Prevent the Risk of HF
  • Panel Discussion

Moderator(s):

  • JoAnn Lindenfeld, MD, Professor of Medicine Director, Advanced Heart Failure and Transplant, Vanderbilt Heart & Lung Institute

Speaker(s):

You must be logged in and own this session in order to post comments.

Gian-carlo giove
4/4/18 10:15 pm

markers in heart failure a little oncology and diabetes, mainly last slides.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content